Humigent, an AI-native company building the intelligence for life sciences, announced the successful close of its Series A funding round, with participation from Z21 Ventures and First Rays Ventures.

At the core of Humigent is a vertically integrated, model-agnostic AI architecture purpose-built for life sciences. Humigent combines HumigentLM, a proprietary 30-billion-parameter life sciences language model, specialized AI agents, a domain-specific context intelligence layer, agentic orchestration, and applied solutions to transform fragmented enterprise data and institutional knowledge into trusted insights, decisions, and actions.